Megan S Schuler1, Terry L Schell2, Eunice C Wong2. 1. RAND Corporation, 20 Park Plaza #920, Boston, MA, 02216, USA. Electronic address: mschuler@rand.org. 2. RAND Corporation, 1776 Main Street, Santa Monica, CA, 90401, USA.
Abstract
OBJECTIVE: To characterize racial/ethnic differences in past-year prescription opioid misuse and heroin use. METHODS: Data on 1,117,086 individuals age 12 and older were from the 1999-2018 National Survey on Drug Use and Health. We compared relative prevalences across 6 racial/ethnic groups for prescription opioid misuse analyses and 4 racial/ethnic groups for heroin analyses. Unadjusted and gender- and age-adjusted prevalences are reported for 5 time periods (1999-2002, 2003-2006, 2007-2010, 2011-2014, 2015-2018). Survey-weighted Poisson regression models with robust variance were used to estimate risk ratios by race/ethnicity and to test for time trends. RESULTS: Prescription opioid misuse was significantly higher among non-Hispanic White individuals than among Black, Hispanic, and Asian individuals across all time periods, yet was highest among Native American individuals in every time period. The relative difference between White and both Hispanic and Asian individuals significantly widened over time, whereas the gap between Black and White individuals significantly decreased. Early in the study period, heroin use was highest among Black and Hispanic individuals. Heroin use among White individuals first surpassed all other groups in 2007-2010 and continued to steadily increase, more than doubling from 1999-2002 to 2015-2018. CONCLUSIONS: While heroin use has risen among all racial/ethnic groups, the demographics of heroin use have changed significantly in the past two decades such that prevalence is now highest among White individuals. Opioid prevention and treatment initiatives should both be informed by the changing demographics of heroin use and seek to reduce opioid-related harms and expand treatment access equitably for all racial/ethnic groups.
OBJECTIVE: To characterize racial/ethnic differences in past-year prescription opioid misuse and heroin use. METHODS: Data on 1,117,086 individuals age 12 and older were from the 1999-2018 National Survey on Drug Use and Health. We compared relative prevalences across 6 racial/ethnic groups for prescription opioid misuse analyses and 4 racial/ethnic groups for heroin analyses. Unadjusted and gender- and age-adjusted prevalences are reported for 5 time periods (1999-2002, 2003-2006, 2007-2010, 2011-2014, 2015-2018). Survey-weighted Poisson regression models with robust variance were used to estimate risk ratios by race/ethnicity and to test for time trends. RESULTS: Prescription opioid misuse was significantly higher among non-Hispanic White individuals than among Black, Hispanic, and Asian individuals across all time periods, yet was highest among Native American individuals in every time period. The relative difference between White and both Hispanic and Asian individuals significantly widened over time, whereas the gap between Black and White individuals significantly decreased. Early in the study period, heroin use was highest among Black and Hispanic individuals. Heroin use among White individuals first surpassed all other groups in 2007-2010 and continued to steadily increase, more than doubling from 1999-2002 to 2015-2018. CONCLUSIONS: While heroin use has risen among all racial/ethnic groups, the demographics of heroin use have changed significantly in the past two decades such that prevalence is now highest among White individuals. Opioid prevention and treatment initiatives should both be informed by the changing demographics of heroin use and seek to reduce opioid-related harms and expand treatment access equitably for all racial/ethnic groups.
Authors: Peter A Muennig; Megan Reynolds; David S Fink; Zafar Zafari; Arline T Geronimus Journal: Am J Public Health Date: 2018-09-25 Impact factor: 9.308
Authors: Ju Nyeong Park; Emaan Rashidi; Kathryn Foti; Michael Zoorob; Susan Sherman; G Caleb Alexander Journal: Drug Alcohol Depend Date: 2020-11-23 Impact factor: 4.492
Authors: Chelsea L Shover; Titilola O Falasinnu; Candice L Dwyer; Nayelie Benitez Santos; Nicole J Cunningham; Rohan B Freedman; Noel A Vest; Keith Humphreys Journal: Drug Alcohol Depend Date: 2020-09-28 Impact factor: 4.492
Authors: Fares Qeadan; Benjamin Tingey; Rona Bern; Christina A Porucznik; Kevin English; Ali I Saeed; Erin Fanning Madden Journal: EClinicalMedicine Date: 2021-06-04
Authors: Nathalie Huguet; Tahlia Hodes; Steffani R Bailey; Miguel Marino; Daniel M Hartung; Robert Voss; Jean O'Malley; Irina Chamine; John Muench Journal: J Prim Care Community Health Date: 2022 Jan-Dec
Authors: Pavani Rangachari; Anuraag Govindarajan; Renuka Mehta; Dean Seehusen; R Karl Rethemeyer Journal: BMC Public Health Date: 2022-02-04 Impact factor: 3.295